Discover 1,444 paid clinical trials in Akron, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,444
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for
Pediatric Migraine
Location: Cleveland OH, Ann Arbor MI, Amherst NY, Cincinnati OH,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04649242
Phase 3, Recruiting
Deep Brain Stimulation for Visuomotor Function in Parkinson's Disease
for
Parkinson's Disease
Location: Cleveland OH
Sponsor: VA Office of Research and Development
Sex: All
Age: 0+
Code: NCT05400499
Recruiting
Intravitreal Faricimab Injections or Fluocinolone Acetonide (0.19 mg) Intravitreal Implants vs Observation for Prevention of VA Loss Due to Radiation Retinopathy
Get alerts for new trials in your area by subscribing now
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)
for
Relapsing Multiple Sclerosis, Multiple Sclerosis
Location: Cleveland OH, Columbus OH, Toledo OH, Detroit MI,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06433752
Recruiting
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of RLS-0071 in Newborns With Moderate or Severe Hypoxic-Ischemic Encephalopathy Undergoing Therapeutic Hypothermia
for
Hypoxic-Ischemic Encephalopathy
Location: Cleveland OH, Morgantown WV, Indianapolis IN,
Sponsor: ReAlta Life Sciences, Inc.
Sex: All
Age: 0
Code: NCT05778188
Phase 2, Phase 3, Recruiting
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
for
Liver Diseases, Alcoholic
Location: Cleveland OH, London, Toronto, Indianapolis IN,
Sponsor: GlaxoSmithKline
Sex: All
Age: 18 - 70
Code: NCT06613698
Phase 2, Recruiting
Phase 2/3 Study of Participants With Recurrent Pericarditis Evaluating the Efficacy and Safety of KPL-387
Clinical Trial of N-803 Plus Tislelizumab or Prior Failed Immune Checkpoint Inhibitor and Docetaxel Versus Docetaxel Monotherapy in Participants With Advanced or Metastatic Non-Small Cell Lung Cancer Who Have Acquired Resistance to Immune Checkpoint Inhibitor Therapy
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
for
Interstitial Lung Disease
Location: Cleveland OH, Chicago IL, Richmond VA, New York NY,
Sponsor: aTyr Pharma, Inc.
Sex: All
Age: 18+
Code: NCT05892614
Phase 2, Recruiting
A Study to Assess the Safety and Clinical Activity of Azer-cel in Participants With B-cell Mediated Autoimmune Disorders
for
B-cell Mediated Autoimmune Disorders
Location: Cleveland OH, Columbus OH, Ann Arbor MI, Rochester NY,
Sponsor: TG Therapeutics, Inc.
Sex: All
Age: 18+
Code: NCT06680037
Phase 1, Recruiting
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer